Publications by authors named "J V Castell"

Urban vegetation provides many ecosystem services like heat island mitigation. However, urban trees are subjected to the stresses that they are meant to alleviate, with drought being a main constraint. We investigated the drought response strategy of plane trees (Platanus × hispanica), focusing on stomatal regulation and metabolic remodelling.

View Article and Find Full Text PDF

Current background tropospheric ozone (O) concentrations have significant adverse effects on wheat. O generally induces oxidative damages and premature leaf senescence leading to important yield losses. As leaf protein degradation and recycling is involved in both maintaining cell longevity during abiotic stresses and performing efficient nitrogen remobilization during senescence, we aimed to identify proteases involved in acidic endoproteolytic activities during natural and O-induced leaf senescence in wheat.

View Article and Find Full Text PDF
Article Synopsis
  • - Valproate (VPA), commonly prescribed for epilepsy in children, can lead to liver issues like hepatic steatosis, but many cases may go unnoticed due to a lack of specific biomarkers.
  • - The study aimed to demonstrate that VPA causes triglyceride accumulation in liver cells and to identify microRNAs (miRNAs) linked to this effect as potential non-invasive biomarkers for liver steatosis in children.
  • - The researchers found that certain miRNAs were significantly altered in children taking VPA, and this signature identified 18 patients at risk for liver steatosis, highlighting a connection between high VPA levels, younger age, and liver enzyme changes.
View Article and Find Full Text PDF

Drug induced fatty liver disease (DIFLD) is a form of drug-induced liver injury (DILI), which can also be included in the more general metabolic dysfunction-associated steatotic liver disease (MASLD), which specifically refers to the accumulation of fat in the liver unrelated to alcohol intake. A bi-directional relationship between DILI and MASLD is likely to exist: while certain drugs can cause MASLD by acting as pro-steatogenic factors, MASLD may make hepatocytes more vulnerable to drugs. Having a pre-existing MASLD significantly heightens the likelihood of experiencing DILI from certain medications.

View Article and Find Full Text PDF

Drug-induced liver injury (DILI) is a serious adverse hepatic event presenting diagnostic and prognostic challenges. The clinical categorization of DILI into hepatocellular, cholestatic, or mixed phenotype is based on serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) values; however, this classification may not capture the full spectrum of DILI subtypes. With this aim, we explored the utility of assessing changes in the plasma metabolomic profiles of 79 DILI patients assessed by the RUCAM (Roussel Uclaf Causality Assessment Method) score to better characterize this condition and compare results obtained with the standard clinical characterization.

View Article and Find Full Text PDF